Don’t Trade in the Dark—Get Your Pre-Market Report Every Day.Join Now
Food, Beverages & Tobacco | Small Cap
Health Score : 4.92Ajooni Biotech Ltd, operating in the FMCG sector, showcases a mixed financial performance. The company demonstrates strong solvency and growth, particularly in operating profit, EPS, and asset growth. However, liquidity remains a significant concern, with all liquidity ratios indicating poor performance. Efficiency ratios are also low, except for days sales in inventory and receivable days. Profitability is a mixed bag, with a strong ROCE but weak gross and net margins. Overall, while the company shows potential for growth and manages its equity well, it needs to address its liquidity and efficiency challenges to ensure long-term financial health.
Health Score : 4.92Ajooni Biotech Ltd, operating in the FMCG sector, showcases a mixed financial performance. The company demonstrates strong solvency and growth, particularly in operating profit, EPS, and asset growth. However, liquidity remains a significant concern, with all liquidity ratios indicating poor performance. Efficiency ratios are also low, except for days sales in inventory and receivable days. Profitability is a mixed bag, with a strong ROCE but weak gross and net margins. Overall, while the company shows potential for growth and manages its equity well, it needs to address its liquidity and efficiency challenges to ensure long-term financial health.
Overall Valuation Score
Markets Depth NSE
Buy Orders
Bid
Quantity
Orders
No buy depth
Total
0
0
Sell Orders
Ask
Quantity
Orders
No sell depth
Total
0
0
Markets Today NSE
High
0.00
Low
0.00
Open
0.00
Close
0.00
Prev Close
0.00
Avg Price
0.00
Volume
0
Last Traded Quantity
0
Last Traded Time
N/A
Price Movement Indicator
Today's Low: 0.00
Today's High: 0.00
P/E RATIO (TTM)
15.00
Industry Median
15.17
Small Cap Median
15.17
P/E RATIO
15.00
P/B RATIO
0.71
Industry Median
1.61
Small Cap Median
1.61
P/S RATIO
0.35
Industry Median
0.76
Small Cap Median
0.76
Others
PEG RATIO
0.00
EV/EBITDA RATIO
7.31
The Calculations Shown Above Are Based on the Last Traded Price (LTP) of ₹3.75 as on Sep 1, 2026.
Growth Score : 6.00The company shows strong growth in operating profit, EPS, and asset growth. However, revenue and net income growth are stagnant. This indicates the company is becoming more profitable and efficient in its operations, but needs to focus on revenue generation to sustain long-term growth.
Revenue Growth RatePoor
Operating Profit Growth RateExcellentEarnings Per Share (EPS) GrowthExcellentAsset Growth RateExcellentNet Income Growth RatePoor| Growth Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue Growth Rate | 45.1 | 0 | 8.11 | 43.75 | 58.26 |
| Operating Profit Growth Rate | 50 | 0 | -33.33 | 100 | 50 |
| Earnings Per Share (EPS) Growth | 150 | 20 | 100 | 66.67 | 25 |
| Asset Growth Rate | 3.57 | 103.45 | -18.64 | 97.92 | 26.32 |
| Net Income Growth Rate | 0 | 100 | 50 | 33.33 |
Revenue Growth Rate
Operating Profit Growth Rate
Earnings Per Share (EPS) Growth
Asset Growth Rate
Net Income Growth Rate
Peer Comparison empowers investors to evaluate a company against its industry peers using key financial metrics like P/E ratio, EPS, and profit margins. It helps identify whether a company is overvalued, undervalued, or performing in line with competitors. Investors can use this data to spot opportunities, assess risks, and make informed decisions. This contextual view adds depth beyond standalone company analysis.
| NO | Company Name | Health Score | P/E Ratio | Valuation | OPM | EPS | Latest Profit & Loss |
|---|---|---|---|---|---|---|---|
| 1 | Baba Food Processing India Ltd | 7.63 | -25.11 | Neutral | 3.00 | 1.88 | -1.00 |
| 2 | Srivari Spices & Foods Ltd | 6.84 | 18.75 | Neutral | 30.00 | 18.87 | 16.00 |
| 3 | Ajooni Biotech Ltd | 4.92 | 15.00 | Neutral | 6.00 | 0.25 | 4.00 |
| 4 | Dangee Dums Ltd | 3.51 | -30.11 | Neutral | 4.91 | -0.09 | -1.39 |
0 Credits RemainingUnlock Deep Technical Insights in Seconds Only with Dhanarthi AI
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 26 Technical Indicators From The 1 Hour Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Analyzing moving average trends and crossovers. Green/Red badges indicate if the current condition passes or fails.
Comparing stock price performance (normalized) against benchmark indices over time.
Recent daily trading volume represented as a bar chart, alongside historical averages.
Current closing price relative to the 52-week highest and lowest prices.
No Stock Reports Available at This Moment.
No Stock News Available at This Moment.
Ajooni Biotech Ltd. is an India-based company primarily engaged in the manufacturing, marketing, and distribution of a diverse range of animal feed, feed supplements, and animal healthcare products. Catering to livestock, poultry, and aquaculture sectors, it aims to provide nutritional solutions for enhanced animal productivity and health across India.
P/E Ratio (TTM): Price to Earnings ratio shows how much an investor pays for every rupee of the company's earnings. Ajooni Biotech Ltd's P/E ratio (TTM) is 15, compared to the industry median of 15.17 and large cap median of 15.17.
P/B Ratio: Price to Book ratio compares a company's market price to its book value per share. Ajooni Biotech Ltd's P/B ratio is 0.71, compared to the industry median of 1.61 and large cap median of 1.61.
P/S Ratio: Price to Sales ratio compares a company's market value to its total revenue. Ajooni Biotech Ltd's P/S ratio is 0.35, compared to the industry median of 0.76 and large cap median of 0.76.
PEG Ratio: PEG ratio adjusts the P/E ratio for expected earnings growth. Ajooni Biotech Ltd's PEG ratio is N/A.
EV/EBITDA Ratio: This ratio compares a company's enterprise value to its earnings before interest, tax, depreciation, and amortization. Ajooni Biotech Ltd's EV/EBITDA ratio is 7.31.
Return on Equity (ROE): ROE measures how much profit a company generates from shareholders' invested capital. Ajooni Biotech Ltd's ROE is 4.40%.
Return on Assets (ROA): ROA measures how efficiently a company converts its assets into net profit. Ajooni Biotech Ltd's ROA is 5%.
Return on Capital Employed (ROCE): ROCE measures how efficiently a company generates profit from all the capital it employs. Ajooni Biotech Ltd's ROCE is 6%.
Operating Margin: Operating margin shows what percentage of revenue remains after covering operating expenses. Ajooni Biotech Ltd's operating margin is 3.30%.
Net Margin: Net margin shows what percentage of revenue converts into final net profit. Ajooni Biotech Ltd's net margin is 2.20%.
Current Ratio: The current ratio measures a company's ability to pay short-term liabilities using short-term assets. Ajooni Biotech Ltd's current ratio is 3.38.
Debt to Equity Ratio: This ratio shows the proportion of debt a company uses relative to shareholders' equity. Ajooni Biotech Ltd's debt-to-equity ratio is 0.02.
Interest Coverage Ratio: This ratio shows how easily a company can pay interest on its outstanding debt from its operating earnings. Ajooni Biotech Ltd's interest coverage ratio is 7.
Dividend Per Share (DPS): DPS shows the total dividend paid per share in the latest financial year. Ajooni Biotech Ltd's DPS is ₹0.
Earnings Per Share (EPS): EPS shows how much profit is allocated to each outstanding share. Ajooni Biotech Ltd's EPS is 25.
(Source line: "Ratios as of 24 Oct 2026, based on last traded price of ₹3.75. Data sourced from BSE/NSE Exchange Filings & Public Terminal Data.")
Founded: 2010
Headquarters: Mohali, Punjab
Core Offerings: Cattle feed, Poultry feed, Aquaculture feed, Feed supplements
Stock Listing: NSE (AJOONI), BSE ({bse})
Promoter: Mr. Simran Singh & Mr. Amandeep Singh
Founded in 2010, Ajooni Biotech Ltd. commenced operations with a focus on animal feed manufacturing. The company gradually expanded its product portfolio to include various types of animal feed and supplements for livestock, poultry, and aquaculture. In 2018, Ajooni Biotech was successfully listed on NSE Emerge, further expanding its market presence and growth opportunities.
| Segment Name | Revenue % | EBITDA |
|---|---|---|
| Animal Feed and Supplements | 100% | Operating Profit |
Animal Feed: Manufacturing and distribution of a comprehensive range of cattle feed, poultry feed, and aquaculture feed tailored for various life stages and nutritional requirements.
Feed Supplements: Offers specialty feed supplements, mineral mixtures, and premixes designed to improve animal health, productivity, and milk yield for dairy, poultry, and fish farming sectors.
Mr. Simran Singh (Chairman & Managing Director): A visionary entrepreneur with extensive experience and leadership in the animal feed industry. Mr. Amandeep Singh (Joint Managing Director): Plays a crucial role in overseeing operational efficiency and strategic expansion initiatives.
No major subsidiaries reported.
No major recent corporate actions on record.
The Ajooni Biotech Ltd share price today is ₹3.75 on NSE (AJOONI), as of 25 Oct 2026.
As of 24 Oct 2026, Ajooni Biotech Ltd share price is ₹3.75, with previous close ₹3.75. Today's range is ₹3.75 to ₹3.75. The 52-week range is ₹2.68 to ₹5.50.
As of today, Ajooni Biotech Ltd's market cap is ₹64.42 crore (Small Cap).
Ajooni Biotech Ltd's current P/E ratio is 15, compared to the FOOD BEVERAGES & TOBACCO sector average of 58.
Ajooni Biotech Ltd's current P/B ratio is 0.71.
Ajooni Biotech Ltd's current dividend yield is N/A. Last dividend of ₹0.00 per share was declared on N/A.
Ajooni Biotech Ltd's EPS (TTM) is ₹25.
Ajooni Biotech Ltd. is an India-based company primarily engaged in the manufacturing, marketing, and distribution of a diverse range of animal feed, feed supplements, and animal healthcare products. Catering to livestock, poultry, and aquaculture sectors, it aims to provide nutritional solutions for enhanced animal productivity and health across India.
Ajooni Biotech Ltd is promoted by Mr. Simran Singh & Mr. Amandeep Singh, holding 26.89% as of 24 Oct 2026.
Ajooni Biotech Ltd is listed on NSE (AJOONI) and BSE ({bse}). Its next quarterly results are expected on August 2024.
Cash Earnings Per Share (Cash EPS)